Pages that link to "Q33302771"
Jump to navigation
Jump to search
The following pages link to Optimal chemotherapy treatment for women with recurrent ovarian cancer (Q33302771):
Displaying 50 items.
- Autologous immune enhancement therapy in recurrent ovarian cancer with metastases: a case report (Q24615762) (← links)
- DNA methylation changes in epithelial ovarian cancer histotypes (Q27690722) (← links)
- Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53 (Q28245322) (← links)
- Reducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer (Q30576727) (← links)
- Phase 2 study of intraperitoneal topotecan as consolidation chemotherapy in ovarian and primary peritoneal carcinoma (Q33379831) (← links)
- Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum (Q33381866) (← links)
- Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II study (Q33386338) (← links)
- A phase I study to characterize the safety, tolerability, and pharmacokinetics of topotecan at 4 mg/m2 administered weekly as a 30-minute intravenous infusion in patients with cancer (Q33386523) (← links)
- Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. (Q33395587) (← links)
- LFG-500, a newly synthesized flavonoid, induces apoptosis in human ovarian carcinoma SKOV3 cells with involvement of the reactive oxygen species-mitochondria pathway (Q33744850) (← links)
- Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer (Q33792003) (← links)
- MicroRNAs in ovarian carcinomas (Q33796565) (← links)
- Percutaneous Fine-Needle 5% Ethanol-Cisplatin Intratumoral Injection Combined with Second-Line Chemotherapy Improves On the Standard of Care in Patients with Platinum-Pretreated Stage IV Non-Small Cell Lung Cancer (Q33912220) (← links)
- BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma (Q34134454) (← links)
- BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis (Q34299655) (← links)
- Potent Anticancer Effects of Bioactive Mushroom Extracts (Phellinus linteus) on a Variety of Human Cancer Cells (Q34575783) (← links)
- Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival (Q34653337) (← links)
- A mathematical model of bimodal epigenetic control of miR-193a in ovarian cancer stem cells (Q34784456) (← links)
- Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells (Q34836634) (← links)
- Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations (Q35050560) (← links)
- Preclinical evaluation on the tumor suppression efficiency and combination drug effects of fermented wheat germ extract in human ovarian carcinoma cells (Q35178056) (← links)
- Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective (Q35223628) (← links)
- P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane (Q35376227) (← links)
- Oncolytic virotherapy for ovarian cancer (Q35597082) (← links)
- Analytical Validation of AmpliChip p53 Research Test for Archival Human Ovarian FFPE Sections (Q35678565) (← links)
- Episensitization: Defying Time's Arrow (Q35726218) (← links)
- Heterogeneity of tumor chemosensitivity in ovarian epithelial cancer revealed using the adenosine triphosphate-tumor chemosensitivity assay (Q35742276) (← links)
- Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies (Q35748477) (← links)
- Salvage Chemotherapy for Patients With Recurrent or Persistent Ovarian Clear Cell Carcinoma: A Retrospective Study of 164 Cases (Q35857892) (← links)
- Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer (Q36369565) (← links)
- Role of NSC319726 in ovarian cancer based on the bioinformatics analyses (Q36399060) (← links)
- Current status and implications of microRNAs in ovarian cancer diagnosis and therapy (Q36517492) (← links)
- Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options (Q36648394) (← links)
- A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it? (Q36689744) (← links)
- PARP inhibitors in ovarian cancer: Clinical evidence for informed treatment decisions (Q36752061) (← links)
- Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis (Q36840009) (← links)
- Profile of erlotinib and its potential in the treatment of advanced ovarian carcinoma (Q36880902) (← links)
- Minireview: stem cell contribution to ovarian development, function, and disease (Q36908928) (← links)
- Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients. (Q37113732) (← links)
- Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer. (Q37370000) (← links)
- Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model (Q37455627) (← links)
- Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer (Q37509512) (← links)
- Mucinous cystadenocarcinoma of the pancreas - outcome following different modes of treatment (Q37647158) (← links)
- Epigenetics of ovarian cancer: from the lab to the clinic (Q37737449) (← links)
- Optimal treatment for relapsing ovarian cancer (Q37799929) (← links)
- Genetic determinants of oxidative stress-mediated sensitization of drug-resistant cancer cells (Q37906428) (← links)
- Oxaliplatin salvage for recurrent ovarian cancer: a single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity (Q38207399) (← links)
- Intermediate clinical endpoints: a bridge between progression-free survival and overall survival in ovarian cancer trials (Q38261859) (← links)
- Chemical ecology of fungi (Q38514165) (← links)
- Cisplatin-, Doxorubicin-, and Docetaxel-Induced Cell Death Promoted by the Aqueous Extract of Solanum nigrum in Human Ovarian Carcinoma Cells. (Q38864663) (← links)